StonvexLoading…
StonvexStonvexStonvexCore line items from VYNE's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Q1 2026 2026-03-31 | Annual 2025 2025-12-31 | Q2 2025 2025-06-30 | Q1 2025 2025-03-31 |
|---|---|---|---|---|
Revenue | $86.00K | $570.00K | $271.00K | $202.00K |
Operating Income | $-3.82M | $-29.75M | $-16.74M | $-9.20M |
Net Income | $-3.58M | $-26.48M | $-14.37M | $-8.61M |
EPS (Diluted) | $-0.08 | $-0.62 | $-0.34 | $-0.20 |
Total Assets | $25.87M | $30.16M | $44.72M | $56.42M |
Total Liabilities | $1.24M | $2.40M | $5.84M | $12.29M |
Cash & Equivalents | $24.63M | $24.03M | $22.05M | $28.21M |
Free Cash Flow OCF − CapEx | Not available | $-33.12M | Not available | Not available |
Shares Outstanding | 33.35M | 33.32M | 19.77M | 15.96M |